Neonatal Nursing Certification Review: Cardiac Section 12.2 – CHF & Other Cardiac Medications (2/2)

🚨 MASTER neonatal digoxin therapy, antiarrhythmic management, and heart failure pharmacology for certification success and safe bedside application! These drugs form the backbone of advanced NICU cardiac care. 👶 This module focuses on medications used in neonatal congestive heart failure, arrhythmia management, and afterload reduction. It integrates drug mechanisms, dosing, monitoring, and safety across diverse patient populations, highlighting digoxin, beta-blockers, amiodarone, vasodilators, and electrolyte optimization. 🎯 HIGH-YIELD EXAM CONTENT ✅ Digoxin: mechanism, digitalization, and narrow therapeutic range ✅ Toxicity signs—GI upset, arrhythmias, electrolyte-driven risk factors ✅ Beta-blockers (propranolol, atenolol): rate control, contraindications, dosing ✅ Antiarrhythmics (amiodarone, flecainide): indications, side effects, monitoring ✅ Vasodilators (nitroprusside, nicardipine): hypertensive crisis and afterload reduction ✅ Electrolyte targets for cardiac stability—K⁺, Mg²⁺, Ca²⁺ balance ✅ Integration of CHF pathophysiology with pharmacologic interventions ✅ Monitoring—renal, hepatic, and cardiac parameters in neonates ✅ Key safety principles and drug interaction alerts 👍 LIKE if this strengthened your neonatal pharmacology confidence 💬 COMMENT your toughest digoxin or antiarrhythmic case 🔔 SUBSCRIBE for more neonatal certification prep modules #NeonatalNursing #CHF #CardiacMedications #Digoxin #Amiodarone #BetaBlockers #Nitroprusside #Nicardipine #Arrhythmia #NeonatalCardiology #NICU #CertificationPrep #NNPExam #CCRN #RNCNIC #CriticalCare #HighYield #Pharmacology #HeartFailure #NeonatalPharmacology